LICHEN CHINA LTD- A (LICN)

KYG5479G1082 - Common Stock

1.93  +0.06 (+3.21%)

After market: 1.94 +0.01 (+0.52%)

Fundamental Rating

5

Overall LICN gets a fundamental rating of 5 out of 10. We evaluated LICN against 83 industry peers in the Professional Services industry. LICN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. LICN has a valuation in line with the averages, but on the other hand it scores bad on growth.



6

1. Profitability

1.1 Basic Checks

In the past year LICN was profitable.
In the past year LICN had a positive cash flow from operations.

1.2 Ratios

LICN has a Return On Assets of 12.72%. This is amongst the best in the industry. LICN outperforms 87.34% of its industry peers.
LICN's Return On Equity of 13.58% is fine compared to the rest of the industry. LICN outperforms 65.82% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.44%, LICN is in the better half of the industry, outperforming 77.22% of the companies in the same industry.
LICN had an Average Return On Invested Capital over the past 3 years of 18.36%. This is significantly above the industry average of 12.69%.
Industry RankSector Rank
ROA 12.72%
ROE 13.58%
ROIC 14.44%
ROA(3y)16.41%
ROA(5y)N/A
ROE(3y)18.52%
ROE(5y)N/A
ROIC(3y)18.36%
ROIC(5y)N/A

1.3 Margins

LICN's Profit Margin of 20.97% is amongst the best of the industry. LICN outperforms 93.67% of its industry peers.
In the last couple of years the Profit Margin of LICN has remained more or less at the same level.
With an excellent Operating Margin value of 30.83%, LICN belongs to the best of the industry, outperforming 94.94% of the companies in the same industry.
LICN's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 61.17%, LICN is doing good in the industry, outperforming 69.62% of the companies in the same industry.
LICN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 30.83%
PM (TTM) 20.97%
GM 61.17%
OM growth 3Y2.47%
OM growth 5YN/A
PM growth 3Y0.13%
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LICN is creating value.
The number of shares outstanding for LICN has been increased compared to 1 year ago.
LICN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

LICN has an Altman-Z score of 13.22. This indicates that LICN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 13.22, LICN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
LICN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.22
ROIC/WACC1.91
WACC7.54%

2.3 Liquidity

A Current Ratio of 9.81 indicates that LICN has no problem at all paying its short term obligations.
LICN has a Current ratio of 9.81. This is amongst the best in the industry. LICN outperforms 98.73% of its industry peers.
A Quick Ratio of 9.79 indicates that LICN has no problem at all paying its short term obligations.
The Quick ratio of LICN (9.79) is better than 98.73% of its industry peers.
Industry RankSector Rank
Current Ratio 9.81
Quick Ratio 9.79

2

3. Growth

3.1 Past

The earnings per share for LICN have decreased strongly by -38.09% in the last year.
LICN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.77% yearly.
LICN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.41%.
Measured over the past years, LICN shows a quite strong growth in Revenue. The Revenue has been growing by 9.04% on average per year.
EPS 1Y (TTM)-38.09%
EPS 3Y9.77%
EPS 5YN/A
EPS Q2Q%-24.21%
Revenue 1Y (TTM)-20.41%
Revenue growth 3Y9.04%
Revenue growth 5YN/A
Sales Q2Q%-29.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.03, which indicates a rather cheap valuation of LICN.
Compared to the rest of the industry, the Price/Earnings ratio of LICN indicates a rather cheap valuation: LICN is cheaper than 96.20% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of LICN to the average of the S&P500 Index (30.84), we can say LICN is valued rather cheaply.
Industry RankSector Rank
PE 6.03
Fwd PE N/A

4.2 Price Multiples

LICN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LICN is cheaper than 97.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.96

4.3 Compensation for Growth

LICN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LICN!.
Industry RankSector Rank
Dividend Yield N/A

LICHEN CHINA LTD- A

NASDAQ:LICN (10/29/2024, 8:22:15 PM)

After market: 1.94 +0.01 (+0.52%)

1.93

+0.06 (+3.21%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap72.86M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 6.03
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.72%
ROE 13.58%
ROCE
ROIC
ROICexc
ROICexgc
OM 30.83%
PM (TTM) 20.97%
GM 61.17%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 9.81
Quick Ratio 9.79
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-38.09%
EPS 3Y9.77%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-20.41%
Revenue growth 3Y9.04%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y